PHA
-
DATABASE (66)
-
ARTICLES (2)
Elaia' focusses on digital and deeptech companies in their seed and growth phases. The firm’s portfolio includes 19 exited companies like Criteo and over 60 investments with a total of €350 million under management.The firm was founded in Paris in 2002 by a group of four professionals in the technology sector, private equity and operations with a cumulative experience of 75 years in investment and financing.
Elaia' focusses on digital and deeptech companies in their seed and growth phases. The firm’s portfolio includes 19 exited companies like Criteo and over 60 investments with a total of €350 million under management.The firm was founded in Paris in 2002 by a group of four professionals in the technology sector, private equity and operations with a cumulative experience of 75 years in investment and financing.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
The investment arm of Taikang Insurance Group, Taikang Asset Management (Taikang Asset) manages RMB 1.9tn worth of assets, including RMB 1.1tn third-party assets, RMB 420bn alternative investment and RMB 440bn pension funds as of June 2020. Investments are mainly in infrastructure sectors such as transportation, energy, utilities, environmental protection, telecoms and real estate.Taikang Asset is an important platform for Taikang Insurance Group to carry out global business. In November 2007, its wholly-owned unit Hong Kong was set up and has received licenses from the Hong Kong stock exchange for businesses including securities dealing, advisory and asset management. In September 2016, Taikang Asset founded Taikang Asset (Beijing), a new equity investment platform, and raised RMB 2bn for its Phase I Industrial Development Fund by May 2017. Apart from managing and utilizing self-owned and insurance capital, the company manages assets for clients and provides advice on asset management. It also issues public security investment funds among other asset management businesses.
The investment arm of Taikang Insurance Group, Taikang Asset Management (Taikang Asset) manages RMB 1.9tn worth of assets, including RMB 1.1tn third-party assets, RMB 420bn alternative investment and RMB 440bn pension funds as of June 2020. Investments are mainly in infrastructure sectors such as transportation, energy, utilities, environmental protection, telecoms and real estate.Taikang Asset is an important platform for Taikang Insurance Group to carry out global business. In November 2007, its wholly-owned unit Hong Kong was set up and has received licenses from the Hong Kong stock exchange for businesses including securities dealing, advisory and asset management. In September 2016, Taikang Asset founded Taikang Asset (Beijing), a new equity investment platform, and raised RMB 2bn for its Phase I Industrial Development Fund by May 2017. Apart from managing and utilizing self-owned and insurance capital, the company manages assets for clients and provides advice on asset management. It also issues public security investment funds among other asset management businesses.
Zhongguancun Longmen Investment
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
LeapFrog Investments is an impact-focused investor, managing over $1.6bn in assets mainly investing in Africa and Asia. Its “profit with purpose” has led to investments in startups that provide healthcare, financial services and insurance for low-income consumers. Since it was founded in 2007, LeapFrog has attracted funds from Prudential, AXA, Swiss Re and Omidyar Network, becoming the first impact investor in the world to reach the $1bn milestone. It’s headquartered in South Africa and Singapore.LeapFrog is best known for its investments in the insurance sector. One of the most prominent companies in its portfolio is BIMA, the mobile-based insurance provider that has provided coverage in Ghana, Bangladesh, Cambodia and many other countries. In 2020, LeapFrog invested in Indonesian startup PasarPolis, which is a broker for a wide range of microinsurance products. In the healthcare and biotechnology sectors, LeapFrog has funded Indian genetic diagnostics company MedGenome, as well as Goodlife Pharmacy, a Kenyan company providing access to affordable medicine in the East African country.
LeapFrog Investments is an impact-focused investor, managing over $1.6bn in assets mainly investing in Africa and Asia. Its “profit with purpose” has led to investments in startups that provide healthcare, financial services and insurance for low-income consumers. Since it was founded in 2007, LeapFrog has attracted funds from Prudential, AXA, Swiss Re and Omidyar Network, becoming the first impact investor in the world to reach the $1bn milestone. It’s headquartered in South Africa and Singapore.LeapFrog is best known for its investments in the insurance sector. One of the most prominent companies in its portfolio is BIMA, the mobile-based insurance provider that has provided coverage in Ghana, Bangladesh, Cambodia and many other countries. In 2020, LeapFrog invested in Indonesian startup PasarPolis, which is a broker for a wide range of microinsurance products. In the healthcare and biotechnology sectors, LeapFrog has funded Indian genetic diagnostics company MedGenome, as well as Goodlife Pharmacy, a Kenyan company providing access to affordable medicine in the East African country.
Lachy Groom is a young San Francisco-based Australian entrepreneur and angel investor who gained recognition as a teenage coder and was founder of Cardnap and PSDtoWP, acquired by PSD2HTML.com. He also ran fintech Stripe until 2018. To date, he has invested in nine early-stage startups. His recent investments include in the $9m second phase of home physiotherapy tech solution SWORD Health's Series A round, in the $3.8m seed round of collaboration platform for data scientists, Deepnote, and in the $2.2m seed round of trading platform Convictional.
Lachy Groom is a young San Francisco-based Australian entrepreneur and angel investor who gained recognition as a teenage coder and was founder of Cardnap and PSDtoWP, acquired by PSD2HTML.com. He also ran fintech Stripe until 2018. To date, he has invested in nine early-stage startups. His recent investments include in the $9m second phase of home physiotherapy tech solution SWORD Health's Series A round, in the $3.8m seed round of collaboration platform for data scientists, Deepnote, and in the $2.2m seed round of trading platform Convictional.
Beijing Zhongguancun Development Qihang Industrial Investment Fund
Beijing Zhongguancun Development Qihang Industrial Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on biotechnology, pharmaceuticals, next-generation information technology, new energy, new materials and intelligent manufacturing.
Beijing Zhongguancun Development Qihang Industrial Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on biotechnology, pharmaceuticals, next-generation information technology, new energy, new materials and intelligent manufacturing.
Founded in 2009, Septwolves Venture Capital is a subsidiary of Septwolves Holding Group Co Ltd. The VC firm currently manages assets worth RMB 1bn.Focusing on investment opportunities in the communications and other traditional industries like logistics, Septwolves also invests in diverse sectors including mobile internet, energy, food, pharmaceutical, textile and software.
Founded in 2009, Septwolves Venture Capital is a subsidiary of Septwolves Holding Group Co Ltd. The VC firm currently manages assets worth RMB 1bn.Focusing on investment opportunities in the communications and other traditional industries like logistics, Septwolves also invests in diverse sectors including mobile internet, energy, food, pharmaceutical, textile and software.
Founded in 2018, Trinity Innovation Fund is a fund management firm that mainly invests in pharmaceutical innovations. TIF currently manages two PE funds and its limited partners include renowned pharmaceuticals and institutional investors. It also has offices managing funds overseas, for example, Trinity Innovation Bioventure Singapore Pte Ltd.
Founded in 2018, Trinity Innovation Fund is a fund management firm that mainly invests in pharmaceutical innovations. TIF currently manages two PE funds and its limited partners include renowned pharmaceuticals and institutional investors. It also has offices managing funds overseas, for example, Trinity Innovation Bioventure Singapore Pte Ltd.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Enagás Emprende, part of the Spanish Transmission System Operator (TS) Enagás, is an investment venture backing and accelerating technology-based startups in their scale-up phase. Its portfolio investment mainly includes companies providing renewable gases, green hydrogen, and biomethane, but also sustainable mobility and energy efficiency. With 50 years of experience in energy infrastructures across Spain, the US, Mexico, Chile, Peru, Albania, Greece and Italy, Enagás provides its portfolio startups with mentoring and expertise acting as investors, clients and industry partners.
Enagás Emprende, part of the Spanish Transmission System Operator (TS) Enagás, is an investment venture backing and accelerating technology-based startups in their scale-up phase. Its portfolio investment mainly includes companies providing renewable gases, green hydrogen, and biomethane, but also sustainable mobility and energy efficiency. With 50 years of experience in energy infrastructures across Spain, the US, Mexico, Chile, Peru, Albania, Greece and Italy, Enagás provides its portfolio startups with mentoring and expertise acting as investors, clients and industry partners.
GoHub Ventures is the Valencia-based corporate venture capital arm of Global Omnium, a company specialised in water management. The firm invests in the seed and scale-up phases with a ticket size between €500,000 - €3m.The comnpany has so far invested €11m until 2020 and is mostly backing deep tech startups working in AI, big data, 3D, IoT and robotics and cybersecurity sectors.
GoHub Ventures is the Valencia-based corporate venture capital arm of Global Omnium, a company specialised in water management. The firm invests in the seed and scale-up phases with a ticket size between €500,000 - €3m.The comnpany has so far invested €11m until 2020 and is mostly backing deep tech startups working in AI, big data, 3D, IoT and robotics and cybersecurity sectors.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
M Capital Partners is a leading private equity firm in the French small-cap market. It specializes in SME financing in the development and transmission phases. Based in Paris, the company has offices in Toulouse, Nice, Montepellier and Bordeaux. Founded 17 years ago, M Capital has €530m under active management. It is engaged in venture and capital investments, real estate, and impact investing. Recently it declared its aim to obtain the B Corp sustainability label, and created a foundation and several positive impact funds and moved to decarbonize its portfolio.
M Capital Partners is a leading private equity firm in the French small-cap market. It specializes in SME financing in the development and transmission phases. Based in Paris, the company has offices in Toulouse, Nice, Montepellier and Bordeaux. Founded 17 years ago, M Capital has €530m under active management. It is engaged in venture and capital investments, real estate, and impact investing. Recently it declared its aim to obtain the B Corp sustainability label, and created a foundation and several positive impact funds and moved to decarbonize its portfolio.
Nickleby Capital is a London-based VC firm that focuses on three main areas: (1) investment capital for companies in the scale-up phase, Series A, Series B, and buyouts, (2) advisory services leveraging proprietary tech, researches and industry network, to accelerate PLCs and private companies' growth, and (3) real estate, advising on commercial and residential properties globally. The firm’s investors are mostly family offices and serial entrepreneurs that have built market-leading companies. The Nickleby Capital’s team is founded by a team of alumni from Goldman Sachs, Rothschild, BDO and Korn Ferry.
Nickleby Capital is a London-based VC firm that focuses on three main areas: (1) investment capital for companies in the scale-up phase, Series A, Series B, and buyouts, (2) advisory services leveraging proprietary tech, researches and industry network, to accelerate PLCs and private companies' growth, and (3) real estate, advising on commercial and residential properties globally. The firm’s investors are mostly family offices and serial entrepreneurs that have built market-leading companies. The Nickleby Capital’s team is founded by a team of alumni from Goldman Sachs, Rothschild, BDO and Korn Ferry.
Bluepha to boost PHA bioplastics production with $30m fresh funding
The Beijing-based startup aims to produce 10,000 tons of PHA bioplastic a year and build a SynBio community through its STEM education spinoff, Bluepha Lab
VEnvirotech: Organic waste converted at source into biodegradable raw bioplastic
The Spanish startup presents an innovative circular business model to stand out in the ever-growing bioplastics sector with its on-site smart-waste container and garbage-consuming bacteria
Sorry, we couldn’t find any matches for “PHA”.
1
POPULAR DATABASE
